ECM Therapeutics announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance (K253521) for ECMT-100 WMD, a flowable extracellular matrix hydrogel intended for the ...
The tumor extracellular matrix (ECM) is increasingly recognized as a key driver of immune suppression and therapy resistance in cancer. However, the specific ECM components and mechanisms that create ...
The extracellular matrix (ECM) is a complex network of proteins and glycoproteins that provides structural support and biochemical cues to cells. In cancer, the dynamic remodelling of the ECM by both ...
Hypertrophic scars (HS) are abnormal outcomes of wound healing, marked by excessive extracellular matrix (ECM) deposition and ...
A new study, led by Prof. Liu from the department of pharmacy, University of Electronic Science and Technology of China, discovered that the extracellular cell matrix (ECM) could induce the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results